Food and Drug Administration Drug Safety Podcast

FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease...

Listen to FDA Drug Safety Podcast titled, FDA adds Boxed Warning for increased risk of severe...

• 0
• 0
• 2 meses

Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of

Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use...

• 0
• 0
• 3 meses

FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia...

Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of...

• 0
• 0
• 4 meses

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to...

• 0
• 0
• 10 meses

FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use

Listen to an audio podcast of the April 13, 2023, FDA Drug Safety Communication, FDA updates...

• 0
• 0
• 11 meses

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis...

• 0
• 0
• 1 año

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)

Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a...

• 0
• 0
• 1 año

FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns

Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer...

• 0
• 0
• 1 año

FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast...

Listen to an audio podcast of the March 30, 2022 FDA Drug Safety Communication Iodinated Contrast...

• 0
• 0
• +1 año

FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)

Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is...

• 0
• 0
• +1 año

FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and ...

Listen to an audio podcast of the January 12, 2022, FDA Drug Safety Communication warning that...

• 0
• 0
• +1 año

FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

“Listen to FDA Drug Podcast, FDA warns that getting alcohol-based hand sanitizer in the eyes can...

• 0
• 0
• +1 año

FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK in...

Listen to an audio podcast of the September 1, 2021 FDA Drug Safety Communication on requiring...

• 0
• 0
• +1 año

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises ...

Listen to an audio podcast of the July 20, 2021 FDA Drug Safety Communication, FDA requests...

• 0
• 0
• +1 año

FDA warns that vapors from alcohol-based hand sanitizers can have side effects

Listen to an audio podcast of the June 16, 2021 Drug Safety Communication "FDA warns that vapors...

• 0
• 0
• +1 año

Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (...

Listen to FDA Drug Safety Podcast on due to risk of serious liver injury, FDA restricts use of...

• 0
• 0
• +1 año

Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) i...

Listen to an audio podcast of the March 31, 2021 FDA Drug Safety Communication that FDA review of...

• 0
• 0
• +1 año

FDA warns that abuse and misuse of the OTC nasal decongestant propylhexedrine can lead to serious harm

Listen to an audio podcast of the March 25, 2021 FDA Drug Safety Communication warning that abuse...

• 0
• 0
• +1 año

Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulce...

Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "Initial safety trial...

• 0
• 0
• +1 año

FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid

Listen to an audio podcast of the October 15, 2020 FDA Drug Safety Communication titled "FDA...

• 0
• 0
• +1 año